In peer-reviewed animal work the concrete numbers are oral doses of roughly 1.442.88 mg/kg given daily to APP/PS1 Alzheimer-model mice over about three months [3] , and low-mg/kg dosing that reversed scopolamine-induced deficits in rodents [1]
Here is a table with some structures and pK a values for amino acids
The difference is that your window of use is much wider, and the margin for error is far more generous
Users stopping retinoids frequently report rapid regression of benefits within 4-8 weeks including increased breakouts sometimes exceeding pre-treatment levels (retinoid rebound), accelerated fine line reappearance approaching or surpassing baseline, skin texture deterioration returning to pre-treatment roughness, and psychological dependency from dramatic visible decline creating pressure for continuous use despite side effect burden
Furthermore, the study showed that the skin barrier functionmeasured by transepidermal water loss (TEWL)was preserved, indicating good tolerance despite the use of an AHA
Evidence for a release of brain-derived neurotrophic factor from the brain during exercise